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Abstract
Background: Recent interest in the function of the nuclear lamina has been provoked by the
discovery of lamin A/C mutations in the laminopathy diseases. However, it is not understood why
mutations in lamin A give such a range of tissue-specific phenotypes. Part of the problem in
rationalising genotype-phenotype correlations in the laminopathies is our lack of understanding of
the function of normal and mutant lamin A. To investigate this we have used photobleaching in
human cells to analyse the dynamics of wild-type and mutant lamin A protein at the nuclear
periphery.
Results: We have found that a large proportion of wild-type lamin A at the nuclear periphery is
immobile, but that there is some slow movement of lamin A within the nuclear lamina. The mobility
of an R482W mutant lamin A was indistinguishable from wild-type, but increased mobility of L85R
and L530P mutant proteins within the nuclear lamina was found. However, the N195K mutant
shows the most enhanced protein mobility, both within the nucleoplasm and within the lamina.
Conclusion: The slow kinetics of lamin A movement is compatible with its incorporation into a
stable polymer that only exchanges subunits very slowly. All of the myopathy-associated lamin A
mutants that we have studied show increased protein movement compared with wild-type. In
contrast, the dynamic behaviour of the lipodystrophy-associated lamin A mutant was
indistinguishable from wild-type. This supports the hypothesis that the underlying defect in lamin A
function is quite distinct in the laminopathies that affect striated muscle, compared to the diseases
that affect adipose tissue. Our data are consistent with an alteration in the stability of the lamin A
molecules within the higher-order polymer at the nuclear lamina in myopathies.
Background
The nuclear lamina is a filamentous network of lamin pro-
teins that underlies the inner nuclear membrane (INM). It
is thought to make connections between both integral
membrane proteins of the INM, and chromatin. It may
therefore play a fundamental role in the functional organ-
isation of the nucleus. Lamins are type V intermediate fil-
ament (IF) proteins, consisting of a central coiled-coil
region, and globular N-terminal and C-terminal domains.
The N-terminal domain has a nuclear localisation signal
(NLS) and most lamins, except for lamin C, are far-
nesylated at their carboxy termini via a CaaX motif [1]
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BMC Cell Biology 2004, 5:46 http://www.biomedcentral.com/1471-2121/5/46(Figure 1A). The mammalian genome contains two lamin
B genes (LamB1 and 2) and lamins A/C. The latter is alter-
natively spliced to produce lamins A and C, as well as
other minor species. Lamin B is expressed in all cell types
and is essential for cell viability. A-type lamins are
expressed in more differentiated cells [2] and are non-
essential for cell viability [3].
Lamins readily form parallel coiled-coil dimers, which
then associate into larger polymers. However, whereas
cytoplasmic IF proteins assemble in vitro into 10 nm fila-
ments that resemble those formed in vivo, lamins assem-
ble in vitro into paracrystalline arrays rather than filaments
[4]. This suggests that, in vivo, assembly of correct lamin
higher-order structures requires the interaction with other
molecules/proteins. Lamin A certainly has the ability to
interact with other proteins, and also to influence their
localisation. In the absence of lamin A, emerin relocates
from the INM to the endoplasmic reticulum [3,5,6]. The
interaction domain with emerin is in the C-terminal
domain of lamin A [7,8]. The coiled-coil region can inter-
act with chromatin [9,10] (Figure 1A). There is also an
interaction between lamins A/C and the INM proteins
LAP2β [11] and muscle-specific nesprin1 [12].
In addition to its localisation at the nuclear lamina, lamin
A is also found within the nucleoplasm where it might
interact with other nuclear proteins. Interaction and/or
co-localisation between lamin A and; Rb, mRNA splicing
factors, LAP2 , sites of early DNA replication, and spe-
cific transcription factors have been reported [13-18].
Recent interest in the function of the nuclear lamina has
been provoked by the discovery of lamin A/C mutations
in several human diseases, termed the laminopathies
[reviewed in [19]]. What is striking about these diseases is
that so many apparently disparate phenotypes arise from
mutations in one widely expressed gene. The overt pheno-
types of the laminopathies can be grouped according to
the major cell types that are affected. Striated (skeletal and
cardiac) muscle is affected in autosomal dominant Emery-
Dreifuss muscular dystrophy (AD-EDMD), limb girdle
muscular dystrophy type 1 (LGMD-1B), and dilated cardi-
omyopathy (DCM). Adipose and bone tissues are affected
in familial partial lipodystrophy (FPLD) and mandibu-
loacral dysplasia (MAD). Charcot-Marie-Tooth neuropa-
thy type 2B1 (CMT2B1) is a demyelination disease of
peripheral neurons. Lastly, Hutchinson-Gilford Progeria
Syndrome (HGPS) [20,21] and atypical Werner's Syn-
drome [22] affect multiple tissue types, including many of
those involved in the other laminopathies (muscle, fat,
bone), and also results in some premature ageing pheno-
types. There are currently three main hypotheses for lam-
inopathy disease mechanisms – nuclear weakness, altered
nuclear-cytoskeletal interactions, or changes in gene
expression [19,23].
To understand the disease pathology of the laminopathies
it will be necessary to better characterise the properties of
mutant lamin As. The mutations in AD-EDMD are distrib-
uted throughout the coiled-coil domain and the first half
of the C-terminal globular domain of lamin A. LGMD and
DCM appear to be caused mainly by mutations in the
coiled-coil domain [19], although an R571S mutation at
the end of the globular domain, that affects only lamin C,
has been found in a mild case of DCM. [24].
Structure of lamin A proteinFigure 1
Structure of lamin A protein.A) Diagram of lamin A 
amino acid sequence showing the domains of the protein, 
and the position of the four laminopathy-associated missense 
mutations in DCM, FPLD and AD-EDMD. B) Structure of the 
C-terminal globular domain of Lamin A showing the relative 
positions of the FPLD associated R482W missense mutation 
and the AD-EDMD associated L530P mutation. (Adapted 
with permission from [25]).
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BMC Cell Biology 2004, 5:46 http://www.biomedcentral.com/1471-2121/5/46In contrast, FPLD and MAD mutations cluster tightly
within part of the C-terminal globular domain. An expla-
nation for this came from structural analysis of this
domain. The residues mutated in FPLD and MAD are on
the surface (solvent exposed), whereas residues mutated
in other laminopathies are located internally within the
hydrophobic core of the domain structure [25,26] (Figure.
1B). The latter mutations may therefore have more pro-
found affects on the structure of the mutant protein,
whereas FPLD and MAD mutations may leave the overall
structure of the lamin A molecule largely unperturbed but
might, for example, interfere with protein-protein
interactions.
To better understand the affects of laminopathy-associ-
ated mutations on lamin A function we have used fluores-
cence recovery after photobleaching (FRAP) and
fluorescence loss in photobleaching (FLIP) to investigate
the protein dynamics of GFP-tagged wild-type and dis-
ease-associated mutant lamin As in living cells.
Results and discussion
Expression of mutant lamin A in human cells
To investigate the biological affect of different mutations
on lamin A nuclear localisation and dynamics we
expressed epitope tagged forms of the protein, carrying
disease-associated missense mutations, in human
HT1080 cells. The mutations chosen were; L85R (DCM),
N195K (DCM), R482W (FPLD), and L530P (AD-EDMD).
Although L85R and N195K are both located within the
coiled-coil domain of lamin A, and associated with DCM
(Figure 1A), they have been shown to have different
behaviours when transiently expressed [27,28]. R482W
and L530P are associated with different disease pheno-
types (lipodystrophy and myopathy, respectively), and
although they are both within the globular domain,
R482W is a surface residue, whilst L530P is internal (Fig-
ure 1B).
Since these mutations are responsible for autosomal dom-
inant forms of disease they should still exert their molec-
ular phenotype in the cell in the presence of wild-type
(wt) protein. Both FLAG-tagged and GFP-tagged prelamin
As were transiently transfected into human fibrosarcoma
cells. Each protein was processed into mature lamin A
[29] and incorporated into the nuclear lamina, as evident
by the bright nuclear ring of staining visualised either by
immunofluorescence with anti-FLAG antibody or from
the GFP signal (Figure 2). The mutant forms of lamin A
generally had a more uneven distribution at the nuclear
periphery, compared to wt, as has been reported previ-
ously [30]. We saw high levels of N195K lamin A in the
nucleoplasm in addition to the nuclear periphery, but we
did not see much evidence for its aggregation into intra-
nuclear foci, as has been reported in mouse myoblasts and
embryonic fibroblasts [27,28],. This might reflect differ-
ences in cell-type or relative expression levels of the
mutant protein. Apparently internal sites of epitope-
tagged lamin As are seen, but analysis of 3D image stacks
(Figure 2B) shows that these are invaginations of the
nuclear periphery and not intra-nuclear foci. Such invagi-
nations has previously been reported in many types of cul-
tured cells [31-33].
Analysis of lamin A dynamics by FRAP
The lamin A mutations that we have studied are within
different domains of the protein (Figure 1A), or within
different parts of the same structural domain (Figure 1B).
Therefore they likely have different interactions, either
with other molecules of lamin A, or with other proteins of
the nuclear periphery or nucleoplasm. Such interactions
affect the kinetic properties of a protein, and
photobleaching and time-lapse imaging can probe this
[34]. We therefore analysed the mobility of GFP tagged wt
and mutant lamin As by FRAP in transiently transfected
human cells.
In each case a region at the nuclear lamina was bleached.
The fluorescence within a 1.8 × 1.8 µm region of interest
(ROI) of this bleach region was then followed every 5
minutes over a period of up to 65 minutes. To calculate
the loss of fluorescence attributed to the imaging process
alone, the sum of pixel intensities was also calculated for
a control (unbleached) cell in each case. This was used to
normalise the fluorescence intensity for each ROI [35].
The mean relative fluorescence intensity for each time
point was then calculated for 9 cells of each of the GFP-
lamin A proteins (WT, L85R, N195K, R482W and L530P).
For wild-type lamin A, fluorescence at the nuclear lamina
is visibly bleached (t = 0 in Figure 3A), and only about
20% of the signal recovers over the time course of the
experiment (Figure 3C). This indicates that a large propor-
tion (~80%) of lamin A at the nuclear periphery is immo-
bile, at least within the time-frame of these experiments.
This is similar to the reported immobility of 60% of lamin
B receptor (LBR) in the INM [36]. The recovery curve
shows that wt lamin A moves back into the bleach area
only very slowly (Figure 3C). The extrapolated t1/2 is
~140 minutes, similar to that reported for lamin B1 (>180
mins) [37]. GFP-tagged lamin C expressed in CHO cells
has also been reported to show very little recovery after 1
hour [33]. Most nuclear proteins e.g. transcription factors,
and even chromatin-associated proteins such as HP1, are
very dynamic with t1/2 values in the range of a few sec-
onds [38]. Even the INM proteins emerin, Lap2β, and
Man1 have recovery halftimes of about 1 minute [39]. The
slow recovery of lamin A is compatible with its incorpora-
tion into a stable polymer that only exchanges subunits
very slowly.Page 3 of 9
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BMC Cell Biology 2004, 5:46 http://www.biomedcentral.com/1471-2121/5/46The recovery kinetics for the R482W lamin A mutant are
indistinguishable from wt and the extrapolated t1/2 = 145
mins (Figure 3C). However, the other lamin A mutants
analysed show significant differences. The L85R and
L530P mutant proteins appear to be more mobile than
wild-type lamin A. They recover more rapidly: t1/2 L85R
= 75 mins, L530P = 80 mins. Compared to wt, a higher
proportion of the L85R fluorescence (35%) also recovers,
suggesting that less of this mutant lamin A is in an immo-
bile fraction.
The most dramatic difference in dynamics was seen for the
N195K mutant. Compared to the other lamin As it does
not bleach to the same extent, and this is attributable to
rapid diffusion of the high levels of nucleoplasmic pro-
tein, since at t = 0 recovery of fluorescence can be seen in
the nucleoplasmic part of the bleach region, but not in the
nuclear periphery itself (Figure 3B). It is known that in
early G1 cells the nucleoplasmic pools of lamin A recovery
their fluorescence immediately following bleaching [37].
However, even within the nuclear periphery fluorescence
recovers within the observation period (Figure 3B, t = 15)
and the t1/2 = 30 mins (Figure 3C). Therefore the N195K
lamin A mutant is considerably more mobile within the
nuclear lamina than wt lamin A, or indeed the other
lamin A mutants studied here.
Analysis of lamin A dynamics by FLIP
To further analyse the movement of lamin A within the
nuclear lamina, and between the lamina and the nucleo-
Sub-cellular localisation of epitope-tagged lamin AsFigure 2
Sub-cellular localisation of epitope-tagged lamin As.A) Detection of FLAG-tagged wt and mutant lamin As transfected 
into human HT1080 fibrosarcoma cells. The FLAG tag was detected by immunofluorescence with M2 anti-FLAG (red in 
merge), in DAPI stained nuclei (blue in merge). Bar = 10 µm. B) Detection of GFP-tagged wt and mutant lamin As transfected 
into human HT1080 fibrosarcoma cells. GFP signal in images collected at 2 µm intervals from the top to the bottom of the 
nucleus is shown in black and white. The merged colour images (far right) show mid-plane images of the GFP signal (green) in 
DAPI stained nuclei (blue). Bar = 10 µm.
 
$%
&


	


$$%
'%
$
'%Page 4 of 9
(page number not for citation purposes)
BMC Cell Biology 2004, 5:46 http://www.biomedcentral.com/1471-2121/5/46FRAP analysis of wild type and mutant lamin Asigure 3
FRAP analysis of wild type and mutant lamin As. A and B) Single z-plane confocal images of GFP-tagged (A) wt and (B) 
N195K lamin A expressing cells. Images were captured before (t = -5) and immediately after (t = 0) photobleaching of an area 
of the nuclear periphery, and at 5 min intervals thereafter. The bleach region is boxed in red. C) Graphs of mean (± s.e.m) rel-
ative fluorescence in the bleach area during FRAP, averaged over 9 cells each. In each graph, data for wt (black) and a mutant 
(red) lamin A are compared.
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BMC Cell Biology 2004, 5:46 http://www.biomedcentral.com/1471-2121/5/46plasm, FLIP experiments were performed on wt, and
N195K and L530P mutant GFP-lamin A expressing cells.
After successive rounds of photobleaching at a region of
the nuclear periphery, the fluorescence at a region of the
nuclear periphery distant from the bleach, and at a region
within the nucleoplasm were measured (Figure 4) in 10
cells each. As in FRAP, the data was normalised for the loss
of fluorescence caused by the successive rounds of
imaging.
For both wt and L530P lamin A there is little loss of fluo-
rescence from either a distant region of the nuclear
periphery, or the nucleoplasm after repeated rounds of
photobleaching (Figure 4B). This reflects the slow FRAP
recovery kinetics of these forms of lamin A (Figure 3). In
contrast, the nucleoplasmic fraction of the N195K mutant
lamin A shows a substantial decrease (24%) in fluores-
cence after successive rounds of bleaching at the nuclear
periphery. This may reflect diffusion into the small region
of nucleoplasm contained within the bleach region, but
could also be due to exchange of protein between the
nucleoplasm and the lamina. A 10% decrease in fluores-
cence is also seen at a non-bleached part of the nuclear
periphery. This suggests that there is enhanced lateral
movement of mutant lamin A within the nuclear lamina
compared to wild-type protein.
Conclusions
For GFP-tagged wild-type lamin A we have determined
that a large proportion of the protein at the nuclear
periphery is immobile (Figure 3), and that any recovery of
fluorescence that does occur there is very slow (t1/2 =
~140 mins). This is consistent with the slow recovery
halftimes of lamin B1 [37], and the incorporation of
lamin A into a stable IF polymer at the nuclear lamina.
Of the four laminopathy-associated mutant forms of
lamin A studied by photobleaching all, except for R482,
FLIP analysis of wild type and mutant lamin Asigure 4
FLIP analysis of wild type and mutant lamin As. A) Single z-plane confocal images of a GFP-tagged wt lamin A expressing 
cell captured before (left) and immediately after (right) a round of photobleaching of an area of the nuclear periphery (red 
box). Fluorescence was also recorded for an unbleached area (blue box) of the nuclear periphery, and a region of the nucleo-
plasm (green box). Bar = 10 µm B) Graphs of mean (± s.e.m) relative fluorescence in the bleach area (red) during successive 
rounds of FLIP, and in unbleached regions of the nuclear periphery (blue). and the nucleoplasm (green). Data are averaged over 
10 cells each for wt lamin A and for the L530P and N195K mutant lamin As.
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BMC Cell Biology 2004, 5:46 http://www.biomedcentral.com/1471-2121/5/46show altered dynamics relative to wt protein. The R482W
mutation is associated with FPLD, and other lamin A
mutations found in this disease are also either a loss of
positive charge at R482, or K486, or the gain of a negative
charge (G465D). The amino acid residues involved all
map to a solvent-exposed surface in the structure of the Ig-
like C-terminal domain [26] (Figure 1B). By NMR and cir-
cular dichroism the structure and thermostability of the
R482W mutant is similar to that of wt lamin A [26]. Our
analysis suggests that the dynamics of the R482W mutant
protein within the cell are also similar to wt. It has been
suggested that FPLD-associated mutations of lamin A do
not destabilise the Ig-like domain of lamin A, but may
alter the interaction of the protein with other cellular
components. The Ig-like lamin A domain interacts with
LAP2α [16], emerin [28], DNA [10] and SREBP1 [18].
Emerin can still interact with R482W lamin A [16],
though altered emerin-lamin A interactions have been
reported for the R482L mutation [40]. Mutations at R482
have a 5-fold lower affinity for DNA binding in in vitro
assays [10], and a slightly lower affinity for SREBP1 [18].
We suggest that if lamin A-protein or -DNA interactions
are perturbed by the R482W mutation they are not suffi-
cient to affect the dynamics of lamin A movement within
the nucleus.
The EDMD-associated L530P mutation is also within the
Ig-like domain (Figure 1), but unlike R482W it is located
inside of the structure and so is predicted to destabilise
protein folding [25,26]. Compared with wild-type and
R482W lamin A, we detected increased mobility of L530P
lamin A within the nuclear lamina by FRAP (Figure 3).
Expression of L530P has been reported to result in
decreased emerin localisation at the INM [30]. Therefore,
the stability of both emerin and lamin A at the nuclear
periphery may be mutually dependent. In the absence of
lamin A, emerin completely fails to localise at the INM
[3,5,6]. Our analysis of protein dynamics suggests that an
altered interaction between emerin and lamin A could
alter the stability of the nuclear lamina, reflected in the
increased mobility of lamin A.
Missense mutations in the coiled-coil domain of lamin A
are associated with the myopathies, not FPLD (Figure 1).
They likely impair the dimerization and formation of
higher-order filaments of lamin A. The increased mobility
of the L85R mutant lamin A, as assayed by FRAP (Figure
3), would be consistent with this. The most dramatic
change in lamin A dynamics was seen with the N195K
form. FRAP indicates that it is considerably more mobile
than wt lamin A (Figure 3). FLIP suggests that there might
be exchange between the nucleoplasmic and lamina pools
of this mutant protein, as well as enhanced mobility
within the nuclear lamina (Figure 4). Like L530P, this
mutation is also in the coiled-coil domain, but clearly has
a more drastic affect on lamin polymerisation and intra-
nuclear dynamics.
Given the genetically dominant nature of many of the
laminopathies, it would be interesting to determine
whether the presence of a mutant lamin A has an affect on
the mobility of the (GFP-tagged) wild-type protein in the
same cells.
FLPD is clinically distinct from AD-EDMD and DCM.
Patients with FPLD do not have striated muscle pathol-
ogy, conversely adipose tissue is normal in AD-EDMD
and DCM. Whereas we find increased mobility of all the
myopathy-associated lamin A mutants we studied, we
cannot distinguish between the protein dynamics of wt
and an FLPD mutant form of lamin A (R482W). We con-
clude that in AD-EDMD and DCM laminopathies the
structure of the nuclear lamina is perturbed in such a way
as to allow for more rapid exchange of lamin A molecules.
In contrast, we suggest that, in this respect, the structure of
the lamin polymer is normal in FPLD.
Methods
Generation of GFP-tagged lamin A constructs
Green Fluorescent Protein (GFP)-tagged human lamin A
cloned in pCDNA-3-EGFP (GFP-HLA) was obtained from
L Karnitz (Mayo Clinic, Rochester). GFP-tagged mutant
lamin As were then generated by transfer from N-terminal
FLAG-tagged fusion constructs [27]. GFP-HLA was
digested with AccI/EcoRI and fragments of 5.4 Kb (the
vector backbone) and 894 bp (GFP coding sequence plus
0–175 bp of lamin A) were purified. FLAG-pre-lamin A
coding sequences (carrying laminopathy mutations) were
then excised from each of the pSVK vectors using EcoRI/
SalI, and cloned into XhoI/EcoRI digested pUC21. A 1.8
kb AccI/SpeI fragment of the coding sequence (removing
the FLAG tag and the first 175 bp of lamin A) was purified.
The AccI site is upstream of each mutant codon and the
SpeI site is downstream of the stop codon. A three way
ligation was then performed of this fragment together
with the 5.4 Kb and 894 bp AccI/EcoRI fragments from
GFP-HLA.
Cell transfection and immunofluorescence
Human HT1080 fibrosarcoma cells were transfected with
plasmids using Lipofectamine™2000 according to the
manufacturer's recommendations. Cells grown on glass
slides were fixed 24 hours later for immunofluorescence
or GFP analysis. Cells were fixed for 10 mins in 4% para-
formaldehyde and permeabilised for 10 mins in 0.05%
Triton-X100. FLAG-tagged proteins were detected with
1:200 dilution of M2 anti-Flag mouse monoclonal anti-
body (Sigma) and 1:100 anti-mouse Texas Red Fab'2
heavy and light chains (Jackson Labs). Slides were coun-
terstained with DAPI and analysed using a Zeiss AxioplanPage 7 of 9
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BMC Cell Biology 2004, 5:46 http://www.biomedcentral.com/1471-2121/5/46microscope fitted with a Xillig CCD camera and a focus
motor to collect images at 0.5 µm intervals in the z plane
[41].
Live cell analysis
Cells were grown on DeltaT 0.17 mm culture dishes
(Bioptechs Inc) and were mounted onto a heated stage
(Bioptechs Inc) on a Zeiss LSM510 confocal microscope.
An objective warmer (Bioptechs Inc) was also used to help
to maintain a stable temperature of the medium in the
culture dish.
Photobleaching
For FRAP, a 1.8 × 1.8 µm region at the nuclear periphery
in the mid-focal plane was bleached with 100 iterations at
100% power of the argon laser running at 6.1 mA (50%
power). The pinhole size for the confocal was set at 1 Airy
unit. The time series software option was used to specify
the appropriate time delay between rounds of 3D image
stack capture. Each bleached cell was imaged with a ×100
objective, in a window that included other non-bleached
cells to allow for relative fluorescence levels to be normal-
ised. Immediately following the bleach, images in the
same z-plane were captured at 1s intervals (t = 0 in Figure
3). Thereafter 3D z-plane stacks were captured of the cell
at 5 min intervals for a further 65 mins, using 8% of laser
power.
Because of the length of FRAP analysis, nuclear rotation,
cell movement and focus drift presented a problem in reg-
istering the bleach ROI between time points. To account
for this, the best z-plane image for the bleach ROI was
selected from each time point 3D stack. Each of these was
then processed by an interactive rotation script (v3.6
IPLAB, Scanalytics) to correct for nuclear rotation and cell
movement. This enabled all images to be superimposed
with the pre-bleach image.
For FLIP, an ROI at the nuclear periphery was bleached
with 10 laser iterations at 100% of 50% total laser output
(~6.1 mA). Following the bleach, 5 images were taken at
2 sec intervals using 8% of laser output. The bleach proce-
dure was repeated for 16 rounds.
In both FRAP and FLIP, the loss of fluorescence attributed
to the imaging process alone was assessed from the sum
of pixel intensities in a control (unbleached) cell, in each
analysis. The relative fluorescence intensity over time was
calculated for each defined ROI using a normalisation
equation [35].
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